Blog - Page 3673 of 5767

TuesdayJan 11, 2011 11:08 am

Pacific Biomarkers, Inc. (PBMC.OB) Awarded Two Major Research Contracts

Pacific Biomarkers, Inc. provides specialized central laboratory and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research. Today, PBI announced they have been awarded major research contracts with two multinational pharmaceutical companies to provide clinical biomarker services. The studies conducted by PBI will involve analysis of biomarkers associated with cardiovascular, metabolic and inflammatory diseases and hepatic and renal injury. Testing for the new contracts will begin as early as Feb. of this year with estimated total revenue to be over $1 million during the life of the contracts. One of the leaders at PBI is…

TuesdayJan 11, 2011 11:05 am

Zentric, Inc. (ZNTR.OB) Charged Up By Growing Battery Market

Zentric Inc., offering an advanced battery technology that combines the high energy of lithium-ion and the low costs of traditional lower power batteries, is in a prime position to grow with an anticipated boom in the global rechargeable batteries market, now expected to top $16 billion by 2015 according to Global Industry Analysts, Inc. Factors behind the increase include the continued growth of the electronics market, the expanding use of rechargeable batteries in the automotive sector, and rising demand from China and the rest of Asia. The market, which had previously been dampened by the sluggish worldwide economy, can also…

TuesdayJan 11, 2011 10:42 am

OriginOil, Inc. (OOIL.OB) Video Chart for Tuesday, January 11, 2011

OOIL has been on a solid climb for two months and looks like it is going to try and make a new high. Yesterday, the chart broke out of a classic bull flag pattern and now the price per share is testing resistance in an attempt to continue the uptrend. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

TuesdayJan 11, 2011 9:31 am

GreenWorld Development Inc. (FRXP.OB) to Bring Water to Africa

With a history of developing innovative, competitive and sustainable products, Florida-based GreenWorld Development, Inc. announced yesterday that the company has its sights set on modernizing the Kenyan water system. Every day, clean water becomes harder and harder to find, especially in Sub-Sahara Africa, which is why the American-Irish “Green and Health Technologies” conglomerate has entered into negotiations with global players in the water technology industry to execute this project. Company representatives remarked that they consider this an important contribution to improving living conditions in Africa. “We are currently setting up GreenWorld Kenya Limited in Nairobi,” says GreenWorld CEO Leo J.…

TuesdayJan 11, 2011 9:27 am

RegeneRX Biopharmaceuticals (RGRX.OB) Shares Up on Financing News

Finding funding can be a difficult and often detrimental to share value for many developmental companies. Often times, discounted rates are required to current share price with value being derived from the bid price. Of course, shareholders often scream “dilution” and are disgusted by the concept. Unfortunately, it is a necessary evil the majority of the time as cash is required to expand developments of companies. When a company can secure financing that is at a premium to share price and work deals for options or warrants that are not detrimental to the share structure, investors should be enthusiastic. This…

MondayJan 10, 2011 3:07 pm

Trilogy Capital Partners to Head-up NIVS IntelliMedia Technology Group Inc. (NIV) Investor Relations

NIVS IntelliMedia Technology Group Inc., a consumer electronics company that designs, manufactures and sells intelligent audio and visual products and mobile phones, today announced it has engaged Trilogy Capital Partners to lead its financial marketing and investor relations initiatives. NIVS is implementing various corporate growth initiatives for 2011 to establish itself as China's preeminent integrated consumer electronics company. As the company continues its focus on innovative research and development and works to expand its product portfolio, recruiting an efficient investor relations firm is integral to carry out its missions. Trilogy provides investor relations services and is expected to drive investor…

MondayJan 10, 2011 1:47 pm

Advanced Voice Recognition Systems, Inc. (AVOI.OB) Reaches Final Stage of Interference Proceedings for 2010

In 2010, Advanced Voice Recognition Systems received notice from the U.S. Patent & Trademark Office (USPTO) of a declaration of an interference relating to the company’s patented voice recognition technology. An interference is a proceeding conducted by the USPTO in instances where two or more parties claim patent rights to the same technology where that technology is patentable to each party but for the existence of the other party. It was back in November of 1995 that Advanced Voice Recognition Systems originally filed a broad based patent application that included 42 claims covering a wide range of automatic speech recognition…

MondayJan 10, 2011 1:41 pm

Medisafe 1 Technologies Corp. (MFTH.OB) Device Endorsed for National Implementation by Israeli Pharmaceuticals Administration

Medisafe 1 Technologies, the developer of a series of patented technologies which use physical locking and barcodes on the patient’s armband to ensure that only the correct prescription medication is administered, reported a much-coveted endorsement from Israel’s Pharmaceuticals Administration (IPA) for the Company’s barcoded syringe locking device. CEO of MFTH, Jacob Elhadad, explained that this endorsement was the culmination of a sequence of meetings with officials from the Israeli Health Ministry (IHM) and that CTO of the IPA was on-hand to conduct the final meeting where endorsement was conferred. Prior to this exciting news, meetings were held with several Directors…

MondayJan 10, 2011 1:38 pm

Cephalon, Inc. (CEPH) and Mesoblast Post Positive Interim Results for Phase 2 Stem Cell Product

Biopharmaceutical company Cephalon Inc. and Mesoblast Limited (ASX: MSB), a leading global developer and manufacturer of biologic products, today announced positive interim results from Mesoblast's ongoing multi-center phase 2 trial of its "off-the-shelf" proprietary adult stem cell product Revascor™ for patients with congestive heart failure. Revascor is an allogeneic cell therapy product designed to reverse congestive heart failure. The product is administered by a minimally invasive cardiac catheterization procedure to damaged areas of the heart; the procedure is performed under local anesthesia while the patient is awake. According to the phase 2 trial results, patients who received a single injection…

MondayJan 10, 2011 1:36 pm

China TransInfo Technology Corp. (CTFO) Awarded $1.8M Contract with PRC Ministry of Transportation

China TransInfo Technology Corp. is a leading provider of comprehensive intelligent transportation solutions and traffic information services in China, operating through its affiliate, China TransInfo Technology Group Co. Ltd. The company today announced it has signed an agreement with the Planning Institute under the PRC Ministry of Transportation (MOT), in which China TransInfo will provide technical development and services for a pilot project to build and operate a traffic data collection, analysis, and service system for national trunk roads. Valued at approximately $1.8 million, the contract will be classified within China TransInfo’s government solutions business. The System includes a data…

Site Search

Company Search